Product Information
OXCARBAZEPINE ER 300 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $4.5729 per EA under NDC 27241023801. Its NADAC has been published 47 times since Aug 6, 2025.
The High Outlier badge above means this manufacturer's average price in the Oxcarbazepine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Ajanta Pharma USA Inc.NDC
27241023801
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OXCARBAZEPINEApproval Type
Generic (ANDA)
FDA Application
ANDA217659On Market Since
2/22/2024
Pharmacological Classes
Price Statistics
The NADAC for OXCARBAZEPINE ER 300 MG TABLET has been published 47 times since Aug 6, 2025, and over the history we have for it it has declined 44.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.5729 per EA |
|---|---|
| All-time high | $9.0124 (Jan 14, 2026) |
| All-time low | $4.5729 (Jun 17, 2026) |
| 52-week high | $9.0124 |
| 52-week low | $4.5729 |
| Median price | $8.3531 |
| Average price | $7.6572 |
| Largest weekly change | -13.7% (Apr 22, 2026) |
| Weeks tracked | 47 |
| Tracking since | Aug 6, 2025 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OXCARBAZEPINE ER 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE ER 300 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $4.5729 per EA (NDC 27241023801), effective Jun 24, 2026.
How has the price of OXCARBAZEPINE ER 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXCARBAZEPINE ER 300 MG TABLET has declined 44.0%. It has been tracked across 47 weekly CMS publications since Aug 6, 2025.
What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE ER 300 MG TABLET?
Since Aug 6, 2025, the NADAC for OXCARBAZEPINE ER 300 MG TABLET has ranged from a low of $4.5729 (Jun 17, 2026) to a high of $9.0124 (Jan 14, 2026), with a median of $8.3531 per EA.
Are there cheaper alternatives to OXCARBAZEPINE ER 300 MG TABLET?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, OXCARBAZEPINE 300 MG TABLET, is $0.1664 per EA — about 96% below OXCARBAZEPINE ER 300 MG TABLET.
Who manufactures OXCARBAZEPINE ER 300 MG TABLET?
OXCARBAZEPINE ER 300 MG TABLET (NDC 27241023801) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification